{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:11:06Z","timestamp":1778123466433,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100032579","name":"Beijing Medical Award Foundation","doi-asserted-by":"crossref","award":["YXJL-2020-0941-0753"],"award-info":[{"award-number":["YXJL-2020-0941-0753"]}],"id":[{"id":"10.13039\/100032579","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sun Yat-Sen University Clinical Research 5010 Program","award":["2016007"],"award-info":[{"award-number":["2016007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-026-02252-5","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:54:32Z","timestamp":1774691672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of an online prognostic risk stratification tool to assist decisions on perioperative chemotherapy for men with luminal early breast cancer"],"prefix":"10.1186","volume":"28","author":[{"given":"Yuxuan","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marshall","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengmeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guolin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyun","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zefei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"2252_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"key":"2252_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.19538\/j.cjps.issn1005-2208.2023.02.04","volume":"43","author":"CS Surgery","year":"2023","unstructured":"[Chinese Society of Breast, Surgery CS, o. S. Chinese Medical Association]. [Clinical practice China guidelines for male breast cancer (2023 edition)]. [CHINESE J PRACTICAL SURGERY]. 2023;43:139\u201343. https:\/\/doi.org\/10.19538\/j.cjps.issn1005-2208.2023.02.04.","journal-title":"[CHINESE J PRACTICAL SURGERY]"},{"key":"2252_CR3","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1056\/NEJMra1707939","volume":"378","author":"SH Giordano","year":"2018","unstructured":"Giordano SH. Breast Cancer in Men. N Engl J Med. 2018;378:2311\u201320. https:\/\/doi.org\/10.1056\/NEJMra1707939.","journal-title":"N Engl J Med"},{"key":"2252_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.21037\/tbcr-24-31","volume":"5","author":"J Li","year":"2024","unstructured":"Li J, et al. Chinese Society of Clinical Oncology (CSCO) Breast Cancer guidelines 2024. Transl Breast Cancer Res. 2024;5:18. https:\/\/doi.org\/10.21037\/tbcr-24-31.","journal-title":"Transl Breast Cancer Res"},{"key":"2252_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1804710","volume":"379","author":"JA Sparano","year":"2018","unstructured":"Sparano JA, et al. Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer. N Engl J Med. 2018;379:111\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1804710.","journal-title":"N Engl J Med"},{"key":"2252_CR6","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","volume":"385","author":"K Kalinsky","year":"2021","unstructured":"Kalinsky K, et al. 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer. N Engl J Med. 2021;385:2336\u201347. https:\/\/doi.org\/10.1056\/NEJMoa2108873.","journal-title":"N Engl J Med"},{"key":"2252_CR7","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology - Breast Cancer, https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf (2025)."},{"key":"2252_CR8","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1200\/jco.22.00069","volume":"40","author":"F Andre","year":"2022","unstructured":"Andre F, et al. Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update. J Clin Oncol. 2022;40:1816\u201337. https:\/\/doi.org\/10.1200\/jco.22.00069.","journal-title":"J Clin Oncol"},{"key":"2252_CR9","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.1002\/cncr.32829","volume":"16","author":"H Pan","year":"2020","unstructured":"Pan H, et al. The effect of chemotherapy on survival in patients with nonmetastatic male breast cancer: A population-based observational study. Cancer 126 Suppl. 2020;16:3830\u20136. https:\/\/doi.org\/10.1002\/cncr.32829.","journal-title":"Cancer 126 Suppl"},{"key":"2252_CR10","doi-asserted-by":"publisher","first-page":"175883592095835","DOI":"10.1177\/1758835920958358","volume":"12","author":"WP Li","year":"2020","unstructured":"Li WP, et al. The role of adjuvant chemotherapy in stage I-III male breast cancer: a SEER-based analysis. Ther Adv Med Oncol. 2020;12:1758835920958358. https:\/\/doi.org\/10.1177\/1758835920958358.","journal-title":"Ther Adv Med Oncol"},{"key":"2252_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1158\/1078-0432.Ccr-19-2424","volume":"26","author":"F Wang","year":"2020","unstructured":"Wang F, et al. Sex Disparity Observed for Oncotype DX Breast Recurrence Score in Predicting Mortality Among Patients with Early Stage ER-Positive Breast Cancer. Clin Cancer Res. 2020;26:101\u20139. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-19-2424.","journal-title":"Clin Cancer Res"},{"key":"2252_CR12","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1200\/jco.2017.76.8861","volume":"36","author":"SA Massarweh","year":"2018","unstructured":"Massarweh SA, et al. Molecular Characterization and Mortality From Breast Cancer in Men. J Clin Oncol. 2018;36:1396\u2013404. https:\/\/doi.org\/10.1200\/jco.2017.76.8861.","journal-title":"J Clin Oncol"},{"key":"2252_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15010148","author":"F Jacobs","year":"2022","unstructured":"Jacobs F, et al Controversies and Opportunities in the Clinical Daily Use of the 21-Gene Assay for Prognostication and Prediction of Chemotherapy Benefit in HR+\/HER2- Early Breast Cancer. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers15010148.","journal-title":"Cancers (Basel)"},{"key":"2252_CR14","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1200\/jco.19.03120","volume":"38","author":"MJ Hassett","year":"2020","unstructured":"Hassett MJ, et al. Management of Male Breast Cancer: ASCO Guideline. J Clin Oncol. 2020;38:1849\u201363. https:\/\/doi.org\/10.1200\/jco.19.03120.","journal-title":"J Clin Oncol"},{"key":"2252_CR15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.6004\/jnccn.2021.0023","volume":"19","author":"WJ Gradishar","year":"2021","unstructured":"Gradishar WJ, et al. NCCN Guidelines\u00ae Insights: Breast Cancer, Version 4.2021. J Natl Compr Canc Netw. 2021;19:484\u201393. https:\/\/doi.org\/10.6004\/jnccn.2021.0023.","journal-title":"J Natl Compr Canc Netw"},{"key":"2252_CR16","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1002\/cncr.34448","volume":"128","author":"JP Leone","year":"2022","unstructured":"Leone JP, et al. Efficacy of neoadjuvant chemotherapy in male breast cancer compared with female breast cancer. Cancer. 2022;128:3796\u2013803. https:\/\/doi.org\/10.1002\/cncr.34448.","journal-title":"Cancer"},{"key":"2252_CR17","doi-asserted-by":"publisher","first-page":"103762","DOI":"10.1016\/j.breast.2024.103762","volume":"76","author":"Y Gao","year":"2024","unstructured":"Gao Y, et al. The features of male breast cancer in China: A real-world study. Breast. 2024;76:103762. https:\/\/doi.org\/10.1016\/j.breast.2024.103762.","journal-title":"Breast"},{"key":"2252_CR18","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1200\/jco.2009.25.6529","volume":"28","author":"ME Hammond","year":"2010","unstructured":"Hammond ME, et al. American Society of Clinical Oncology\/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28:2784\u201395. https:\/\/doi.org\/10.1200\/jco.2009.25.6529.","journal-title":"J Clin Oncol"},{"key":"2252_CR19","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/1471-0528.13244","volume":"122","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BJOG. 2015;122:434\u201343. https:\/\/doi.org\/10.1111\/1471-0528.13244.","journal-title":"BJOG"},{"key":"2252_CR20","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1200\/jco.20.02063","volume":"39","author":"A Magnuson","year":"2021","unstructured":"Magnuson A, et al. Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer. J Clin Oncol. 2021;39:608\u201318. https:\/\/doi.org\/10.1200\/jco.20.02063.","journal-title":"J Clin Oncol"},{"key":"2252_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2011","unstructured":"White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med. 2011;30:377\u201399. https:\/\/doi.org\/10.1002\/sim.4067.","journal-title":"Stat Med"},{"key":"2252_CR22","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.healun.2023.06.006","volume":"42","author":"A Ashfaq","year":"2023","unstructured":"Ashfaq A, et al. Survival analysis for pediatric heart transplant patients using a novel machine learning algorithm: A UNOS analysis. J Heart Lung Transpl. 2023;42:1341\u20138. https:\/\/doi.org\/10.1016\/j.healun.2023.06.006.","journal-title":"J Heart Lung Transpl"},{"key":"2252_CR23","doi-asserted-by":"publisher","first-page":"106077","DOI":"10.1016\/j.compbiomed.2022.106077","volume":"150","author":"MAB Hameed","year":"2022","unstructured":"Hameed MAB, Alamgir Z. Improving mortality prediction in Acute Pancreatitis by machine learning and data augmentation. Comput Biol Med. 2022;150:106077. https:\/\/doi.org\/10.1016\/j.compbiomed.2022.106077.","journal-title":"Comput Biol Med"},{"key":"2252_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giac013","author":"A Le Perez-Lebel","year":"2022","unstructured":"Perez-Lebel A, Varoquaux G, Le Morvan M, Josse J, Poline JB Benchmarking missing-values approaches for predictive models on health databases. Gigascience. 2022. https:\/\/doi.org\/10.1093\/gigascience\/giac013.","journal-title":"Gigascience"},{"key":"2252_CR25","first-page":"212","volume":"21","author":"S P\u00f6lsterl","year":"2020","unstructured":"P\u00f6lsterl S. scikit-survival: a library for time-to-event analysis built on top of scikit-learn. J Mach Learn Res. 2020;21:212.","journal-title":"J Mach Learn Res"},{"key":"2252_CR26","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1200\/jco-24-01507","volume":"43","author":"L Pusztai","year":"2025","unstructured":"Pusztai L, et al. Development and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor-Positive, Node-Positive Breast Cancer. J Clin Oncol. 2025;43:919\u201328. https:\/\/doi.org\/10.1200\/jco-24-01507.","journal-title":"J Clin Oncol"},{"key":"2252_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/annonc\/mdx651","volume":"29","author":"F Cardoso","year":"2018","unstructured":"Cardoso F, et al. Characterization of male breast cancer: results of the EORTC 10085\/TBCRC\/BIG\/NABCG International Male Breast Cancer Program. Ann Oncol. 2018;29:405\u201317. https:\/\/doi.org\/10.1093\/annonc\/mdx651.","journal-title":"Ann Oncol"},{"key":"2252_CR28","doi-asserted-by":"publisher","first-page":"e70061","DOI":"10.1002\/cncr.70061","volume":"131","author":"AN Giaquinto","year":"2025","unstructured":"Giaquinto AN, Freedman RA, Newman LA, Jemal A, Siegel RL. Lobular breast cancer statistics, 2025. Cancer. 2025;131:e70061. https:\/\/doi.org\/10.1002\/cncr.70061.","journal-title":"Cancer"},{"key":"2252_CR29","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/jamaoncol.2019.2803","volume":"5","author":"F Wang","year":"2019","unstructured":"Wang F, et al. Overall Mortality After Diagnosis of Breast Cancer in Men vs Women. JAMA Oncol. 2019;5:1589\u201396. https:\/\/doi.org\/10.1001\/jamaoncol.2019.2803.","journal-title":"JAMA Oncol"},{"key":"2252_CR30","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/jnci\/djac241","volume":"115","author":"JP Leone","year":"2023","unstructured":"Leone JP, et al. Survival in male breast cancer over the past 3 decades. J Natl Cancer Inst. 2023;115:421\u20138. https:\/\/doi.org\/10.1093\/jnci\/djac241.","journal-title":"J Natl Cancer Inst"},{"key":"2252_CR31","doi-asserted-by":"publisher","first-page":"1068187","DOI":"10.3389\/fonc.2023.1068187","volume":"13","author":"Y Wen","year":"2023","unstructured":"Wen Y, et al. A nomogram for predicting the risk of male breast cancer for overall survival. Front Oncol. 2023;13:1068187. https:\/\/doi.org\/10.3389\/fonc.2023.1068187.","journal-title":"Front Oncol"},{"key":"2252_CR32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12911-023-02166-8","volume":"23","author":"X Zhao","year":"2023","unstructured":"Zhao X, Jiang C. The prediction of distant metastasis risk for male breast cancer patients based on an interpretable machine learning model. BMC Med Inf Decis Mak. 2023;23:74. https:\/\/doi.org\/10.1186\/s12911-023-02166-8.","journal-title":"BMC Med Inf Decis Mak"},{"key":"2252_CR33","doi-asserted-by":"publisher","first-page":"227","DOI":"10.6004\/jnccn.2025.7014","volume":"23","author":"YW Hsiao","year":"2025","unstructured":"Hsiao YW, Wishart GC, Pharoah PDP, Peng PC. Assessing the Performance of the PREDICT Breast Version 3.0 Prognostic Tool in Patients With Breast Cancer in the United States. J Natl Compr Canc Netw. 2025;23:227\u201333. https:\/\/doi.org\/10.6004\/jnccn.2025.7014.","journal-title":"J Natl Compr Canc Netw"},{"key":"2252_CR34","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/bjs.11748","volume":"107","author":"SE Ward","year":"2020","unstructured":"Ward SE, et al. Bridging the Age Gap: a prognostic model that predicts survival and aids in primary treatment decisions for older women with oestrogen receptor-positive early breast cancer. Br J Surg. 2020;107:1625\u201332. https:\/\/doi.org\/10.1002\/bjs.11748.","journal-title":"Br J Surg"},{"key":"2252_CR35","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1056\/NEJMoa2305488","volume":"390","author":"D Slamon","year":"2024","unstructured":"Slamon D, et al. Ribociclib plus Endocrine Therapy in Early Breast Cancer. N Engl J Med. 2024;390:1080\u201391. https:\/\/doi.org\/10.1056\/NEJMoa2305488.","journal-title":"N Engl J Med"},{"key":"2252_CR36","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1200\/jco.20.02514","volume":"38","author":"SRD Johnston","year":"2020","unstructured":"Johnston SRD, et al. Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE). J Clin Oncol. 2020;38:3987\u201398. https:\/\/doi.org\/10.1200\/jco.20.02514.","journal-title":"J Clin Oncol"},{"key":"2252_CR37","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1200\/jco.19.00647","volume":"37","author":"HB Muss","year":"2019","unstructured":"Muss HB, et al. Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial. J Clin Oncol. 2019;37:2338\u201348. https:\/\/doi.org\/10.1200\/jco.19.00647.","journal-title":"J Clin Oncol"},{"key":"2252_CR38","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/s0140-6736(25)00832-3","volume":"406","author":"E Brain","year":"2025","unstructured":"Brain E, et al. Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial. Lancet. 2025;406:489\u2013500. https:\/\/doi.org\/10.1016\/s0140-6736(25)00832-3.","journal-title":"Lancet"},{"key":"2252_CR39","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/bcr3116","volume":"14","author":"I Johansson","year":"2012","unstructured":"Johansson I, et al. Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker. Breast Cancer Res. 2012;14:R31. https:\/\/doi.org\/10.1186\/bcr3116.","journal-title":"Breast Cancer Res"},{"key":"2252_CR40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13058-020-01266-x","volume":"22","author":"SQ Qiu","year":"2020","unstructured":"Qiu SQ, et al. High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer. Breast Cancer Res. 2020;22:30. https:\/\/doi.org\/10.1186\/s13058-020-01266-x.","journal-title":"Breast Cancer Res"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02252-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02252-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02252-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T02:21:08Z","timestamp":1778120468000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02252-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2252"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02252-5","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Clinical Research and Laboratory Animal Ethics Committee, the First Affiliated Hospital of Sun Yat-sen University (No. [2021]516). Consents were waived due to its retrospective nature and no sensitive personal information collected.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}